Seasonal Influenza: An Overview

Journal of School Nursing

Volumn 25, Issue 1 SUPPL.1, 2009, Pages

  Li, Christina ^a   Freedman, Marian ^a  

^a NONE

Author keywords

Annual vaccination; Attenuated influenza vaccine; Chemoprophylaxis; Inactivated influenza vaccine; Influenza related complications; Live; Trivalent

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ADOLESCENT; ADULT; CHILD; DISEASE TRANSMISSION; HUMAN; IMMUNOLOGY; INFANT; INFLUENZA; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REVIEW; VACCINATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; VACCINATION;

EID: 65449170122     PISSN: 10598405     EISSN: 15468364     Source Type: Journal    
DOI: 10.1177/1059840508330066     Document Type: Article

References (20)

1. American Academy of Pediatrics, Committee on Infectious Diseases. (2008a). Prevention of influenza: Recommendations for influenza immunization of children, 2007-2008. Pediatrics, 121, e1016-e1031.
2. American Academy of Pediatrics, Committee on Infectious Diseases. (2008b). Prevention of influenza: Recommendations for influenza immunization of children, 2008-2009. Pediatrics, 122, 1135-1141.
3. Belshe, R. B., Edwards, K. M., Vesikari, T., Black, S. V., Walker, R. E., & Hultquist, M., et al. (2007). Live attenuated versus inactivated influenza vaccine in infants and children. New England Journal of Medicine, 356, 685-696.
4. Centers for Disease Control and Prevention. (2008a). Influenza. In W. Atkinson, J. Hamborsky, L. McIntyre, & S. Wolfe (Eds.), Epidemiology and prevention of vaccine-preventable diseases (the "Pink Book") (10th ed., pp. 235-255). Washington, DC: Public Health Foundation. Retrieved November 10, 2008, from http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm
5. Centers for Disease Control and Prevention. (2008b). Influenza vaccination coverage among children aged 6-59 months-eight immunization information system sentinel sites, United States, 2007-08 influenza season. Morbidity and Mortality Weekly Report, 57(38), 1043-1046.
6. Centers for Disease Control and Prevention. (2008c). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. Morbidity and Mortality Weekly Report, 57(RR-7), 1-59.
7. Centers for Disease Control and Prevention. (2008d). Selecting the viruses in the influenza (flu) vaccine. Retrieved November 11, 2008, from http://www.cdc.gov/flu/professionals/vaccination/virusqa.htm
8. Centers for Disease Control and Prevention. (2008e). State-specific influenza vaccination coverage among adults-United States, 2006-07 influenza season. Morbidity and Mortality Weekly Report, 57(38), 1033-1039.
9. Heron, M. (2007). Deaths: Leading causes for 2004. National Vital Statistics Reports, 56(5), 8.
10. Johnson, D. R., Nichol, K. L., & Lipczynski, K. (2008). Barriers to adult immunization. American Journal of Medicine, 121, S28-S35.
11. Li, C., Freedman, M., & Boyer-Chu, L. (2009). Championing school-located influenza immunization: The school nurse's role. Journal of School Nursing, supplement to 25(1), 18S-28S.
12. MedImmune, LLC. FluMist® prescribing information. (2008). Retrieved November 14, 2008, from www.medimmune.com/pdf/products/flumist_pi.pdf
13. Molinari, N. M., Ortega-Sanchez, I. R., Messonnier, M. L., Thompson, W. W., Wortley, P. M., & Weintraub, E., et al. (2007). The annual impact of seasonal influenza in the US: Measuring disease burden and costs. Vaccine, 25, 5086-5096.
14. Neuzil, K. M., Hohlbein, C., & Zhu, Y. (2002). Illness among school-children during influenza season: Effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Archives of Pediatrics and Adolescent Medicine, 156, 986-991.
15. Nichol, K. L. (2001). Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Archives of Internal Medicine, 161, 749-759.
16. Piedra, P. A., Gaglani, M. J., Kozinetz, C. A., Herschler, G. B., Fewlass, C., & Harvey, D., et al. (2007). Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics, 120, e553-e564.
17. Poland, G. A., & Johnson, D. R. (2008). Increasing influenza vaccination rates: The need to vaccinate throughout the entire influenza season. American Journal of Medicine, 121, S3-S10.
18. Prosser, L. A., Bridges, C. B., Uyeki, T. M., Hinrichsen, V. L., Meltzer, M. I., & Molinari, N. M., et al. (2006). Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerging Infectious Diseases, 12, 1548-1558.
19. Stinchfield, P. K. (2008). Practice-proven interventions to increase vaccination rates and broaden the immunization season. American Journal of Medicine, 121, S11-S21.
20. US Department of Health and Human Services. (2000). Immunization and infectious diseases. In Healthy People 2010: Vol. 1.Understanding and improving health & objectives for improving health. Part A: Focus Areas 1-14 (2nd ed.). Washington, DC: U.S. Government Printing Office. Retrieved October 17, 2008, from the Healthy People 2010 Web site: http://www.healthypeople.gov/Document/pdf/Volume1/14Immunization.pdf